IVI's PGT-A: A Crucial Tool in Fertility Treatments

IVI specialists emphasize preimplantation genetic testing for aneuploidy (PGT-A) as a vital method in assisted reproduction. This testing identifies chromosomal abnormalities in embryos before transfer, which can prevent unsuccessful pregnancies, particularly for patients with recurrent miscarriage or implantation failures.

According to Dr. Jakob Doblinger at IVI Valencia, PGT-A offers essential insights, especially for those facing complex fertility challenges like advanced maternal age or known genetic conditions. By selecting embryos with chromosomal integrity, it reduces failed treatment attempts and the emotional toll for patients. Approximately 15–20% of IVI's patients have experienced previous implantation failures.

IVI, with over 35 years of expertise, employs PGT-A routinely. This technique attracts patients from countries like Germany, where genetic testing is heavily regulated. Spain, particularly IVI, stands out for its advanced reproductive technologies and personalized treatment strategies.